Theragnostic Imaging
Theragnostic Imaging
News
People
Events
Publications
RNTreg
Contact
Monika Kvassheim
Latest
Assessing the feasibility of quantitative SPECT imaging for low 212Pb activity concentrations using anthropomorphic phantoms
Therapeutic evaluation of [212Pb]Pb-AB001 and [177Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer
Twisted clustered pinhole collimation for improved high-energy preclinical SPECT/PET
Imaging of 212Pb in mice with a clinical SPECT/CT
Optimized SPECT Imaging of 224Ra α-Particle Therapy by 212Pb Photon Emissions
Correction to: Quantitative SPECT/CT imaging of lead-212: a phantom study
Radionuclides for Targeted Therapy: Physical Properties
Quantitative SPECT/CT imaging of lead-212: a phantom study